NCT04042103View on ClinicalTrials.gov

Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 23, 2019

Primary Completion Date

January 9, 2020

Study Completion Date

January 9, 2020

Conditions
Plaque Psoriasis
Interventions
DRUG

Tapinarof cream, 1%

Tapinarof cream, 1% applied topically once daily

Trial Locations (6)

19103

Dermavant Investigational Site, Philadelphia

32771

Dermavant Investigational Site, Sanford

78213

Dermavant Investigational Site, San Antonio

78759

Dermavant Investigational Site, Austin

91436

Dermavant Investigational Site, Encino

99202

Dermavant Investigational Site, Spokane

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT04042103 - Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis | Biotech Hunter | Biotech Hunter